Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.
about
PINP: a new method of tagging neuronal populations for identification during in vivo electrophysiological recording.Herpes simplex virus ICP27 protein directly interacts with the nuclear pore complex through Nup62, inhibiting host nucleocytoplasmic transport pathwaysFormation of nuclear foci of the herpes simplex virus type 1 regulatory protein ICP4 at early times of infection: localization, dynamics, recruitment of ICP27, and evidence for the de novo induction of ND10-like complexesNeuroanatomy goes viral!Axonal transport of AAV9 in nonhuman primate brain.Corticostriatal neurons in auditory cortex drive decisions during auditory discrimination.Cytomegalovirus replicon-based regulation of gene expression in vitro and in vivo.Comparison of AAV serotypes for gene delivery to dorsal root ganglion neurons.DNA repair proteins affect the lifecycle of herpes simplex virus 1.Long-term Cre-mediated retrograde tagging of neurons using a novel recombinant pseudorabies virusVisualization of cortical projection neurons with retrograde TET-off lentiviral vectorHerpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity.Herpes simplex virus-based vectors.HSV trafficking and development of gene therapy vectors with applications in the nervous system.Versatility of gene therapy vectors through viruses.Gene therapy for the treatment of sensory neuropathy.Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociceptionGene therapy for the treatment of diabetic neuropathy.Delivery of RNA interference triggers to sensory neurons in vivo using herpes simplex virus.Optogenetics: potentials for addiction research.Viral vectors for gene delivery to the central nervous system.Gene therapy: a potential approach for cancer pain.Replication-defective HSV-1 effectively targets trigeminal ganglion and inhibits viral pathopoiesis by mediating interferon gamma expression in SH-SY5Y cells.Defining nervous system susceptibility during acute and latent herpes simplex virus-1 infection.The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) blocks apoptosis in hippocampal neurons, involving activation of the MEK/MAPK survival pathway.A protein encoded by the herpes simplex virus (HSV) type 1 2-kilobase latency-associated transcript is phosphorylated, localized to the nucleus, and overcomes the repression of expression from exogenous promoters when inserted into the quiescent HSVDeletion of the virion host shutoff protein (vhs) from herpes simplex virus (HSV) relieves the viral block to dendritic cell activation: potential of vhs- HSV vectors for dendritic cell-mediated immunotherapy.Efficient delivery of RNA Interference to peripheral neurons in vivo using herpes simplex virus.Herpes simplex virus type 1 induces CD83 degradation in mature dendritic cells with immediate-early kinetics via the cellular proteasome.Neuroprotective effects of virally delivered HSPs in experimental stroke.Herpes simplex virus type 1 infection induces the stabilization of p53 in a USP7- and ATM-independent manner.Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids.Functional expression of ATM gene carried by HSV amplicon vector in vitro and in vivo.A Cre-dependent, anterograde transsynaptic viral tracer for mapping output pathways of genetically marked neurons.RNA interference with special reference to combating viruses of crustacea.Innocuous full-length botulinum neurotoxin targets and promotes the expression of lentiviral vectors in central and autonomic neurons.Comparative analysis of genomic HSV vectors for gene delivery to motor neurons following peripheral inoculation in vivo.Manipulating fear associations via optogenetic modulation of amygdala inputs to prefrontal cortex.Novel therapeutic strategy for stroke in rats by bone marrow stromal cells and ex vivo HGF gene transfer with HSV-1 vector.Cellular Antisilencing Elements Support Transgene Expression from Herpes Simplex Virus Vectors in the Absence of Immediate Early Gene Expression
P2860
Q21562431-9494DA8A-6106-4A4A-AB3B-8AE74CD124DFQ24305296-CA138F25-C61C-447D-A919-5ED895C31770Q24607261-3896146A-83C2-46C9-B07B-DE3EC55749C7Q26802140-366CD2C8-F41C-4891-AA29-659C0BB8C37EQ27323331-03783F39-6DF8-4F4F-9417-1B2436810165Q30446866-E87CC7C4-7F94-48E3-98B2-974D407846D6Q31063997-CCACA8D5-B5FE-4308-B05F-4B411ACDD2F9Q33822237-931785D5-B618-42DB-A174-50AFDD859637Q33936284-7DCF0615-F992-4972-B867-E3B6D546E9ACQ34127093-423569E8-5488-4CE1-A983-9117BB21AA99Q34446974-4F00CBD2-21CA-4796-8CF8-4364C8567D7BQ35280041-CDE6EC41-9B52-4E90-BEA4-6C4C94A01626Q35863367-65B03769-F307-4314-BECA-B4E2408DE8A5Q36134871-AA0F2D1F-A34F-4596-9353-8A2CA7F33923Q36150489-E29D2967-42B5-4D6F-A428-3D59F7AC9001Q36446943-BCB04273-BBF3-455D-9913-7986EE80C906Q36634794-686A0C7A-8D72-4833-BDAF-E8075EF538C7Q37319721-A4A5E53D-C969-4D3D-981B-ACE809ED821CQ37737316-410AAE28-28E4-4404-B42A-0B71DF6D8AA6Q37935104-DCFF7396-2781-4122-83CE-9BC90EAABFB2Q37946113-F8E65CBF-9B13-41DA-82A2-718C389E5C70Q38745962-D23F2022-9951-4EFB-AE76-CC58E9895F4AQ39042425-F55CF726-934C-4E3E-9A3B-2655A4B8578AQ39182595-C3FE0BE5-00E8-4F7E-BEEF-3331B0E70AECQ39682246-88C1CBB7-588F-489D-B355-F0E6E98B6C4CQ39683145-B154E70C-3B46-408D-ACAD-4836F299AF2AQ39732678-CC8176C5-7FB0-4C0C-966C-0B0D08294713Q39967822-1093666F-F735-4711-AF24-44C6901B1DF4Q40146699-692B0243-88F5-456C-B723-D26141DC1AD2Q40389152-AD32A7EE-E78E-4DFE-982D-169D2B48120CQ40535811-E8A6E3EA-B45E-4314-B3B1-EB5C0F68473DQ40585361-8D533D16-BDD7-47B3-AB39-53762474A28FQ40606308-8CF45D36-BD00-462D-A185-2EA4943E21D6Q40950555-FAFCB55E-9A79-4849-B399-D8FA268CC1A4Q42272671-9DDE3DEF-5E00-47F6-AA7C-AA9D99BC8B3AQ45867838-D5ABA571-2B9A-4E89-A143-41449DEE1A5CQ45875544-90A2C7F2-9466-4D1C-A92E-F21E7E153555Q47335607-4B0CA086-13F7-4644-9264-8AB61E4AFFBEQ48682582-F42266D1-BC5C-43AF-8CCE-57D28D2ACF6AQ57169063-AB74B4B7-36D2-49D9-967B-ABE2BA1FACE1
P2860
Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Multiple immediate-early gene- ...... entral nervous system in vivo.
@en
type
label
Multiple immediate-early gene- ...... entral nervous system in vivo.
@en
prefLabel
Multiple immediate-early gene- ...... entral nervous system in vivo.
@en
P2093
P2860
P1433
P1476
Multiple immediate-early gene- ...... entral nervous system in vivo.
@en
P2093
C E Lilley
D S Latchman
J A Palmer
P N Anderson
R S Coffin
P2860
P304
P356
10.1128/JVI.75.9.4343-4356.2001
P407
P577
2001-05-01T00:00:00Z